Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Katayoon Goodarzi, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Leiva O, Jenkins A, Rosovsky RP, Leaf RK, Goodarzi K, Hobbs G. Predictors of increased risk of adverse cardiovascular outcomes among patients with myeloproliferative neoplasms and atrial fibrillation. J Cardiol. 2022 Oct 29. PMID: 36384716.
    Citations:    Fields:    
  2. Leiva O, Ren S, Neuberg D, Bhatt A, Jenkins A, Rosovsky R, Karp Leaf R, Goodarzi K, Hobbs G. Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease. Int J Hematol. 2023 Jan; 117(1):90-99. PMID: 36183283.
    Citations:    Fields:    Translation:Humans
  3. Leiva O, Campia U, Snyder J, Barns BM, Rizzo S, Khairani CD, Brunner A, Al-Samkari H, Leaf RK, Rosovsky R, Goodarzi K, Bornikova L, Fathi A, Goldhaber SZ, Hobbs G, Piazza G. Patients with myeloproliferative neoplasms and COVID-19 have increased rates of arterial thrombosis. Res Pract Thromb Haemost. 2022 Jul; 6(5):e12752. PMID: 35979196.
  4. Al-Samkari H, Leaf RK, Goodarzi K. Transient Thrombocytopenia With Glycoprotein-Specific Platelet Autoantibodies After Ad26.COV2.S Vaccination: A Case Report. Ann Intern Med. 2021 11; 174(11):1632-1633. PMID: 34516272.
    Citations: 1     Fields:    Translation:Humans
  5. Song AB, Goodarzi K, Karp Leaf R, Kuter DJ, Al-Samkari H. Thrombopoietin level predicts response to treatment with romiplostim in chemotherapy-induced thrombocytopenia. Am J Hematol. 2021 12 01; 96(12):1563-1568. PMID: 34453757.
    Citations:    Fields:    Translation:Humans
  6. Smibert OC, Catalano OA, Goodarzi K, Roberts MB. Case 23-2021: A 41-Year-Old Woman with Bloody Stools and Thrombocytopenia. N Engl J Med. 2021 07 29; 385(5):451-460. PMID: 34320292.
    Citations:    Fields:    Translation:Humans
  7. Al-Samkari H, Parnes AD, Goodarzi K, Weitzman JI, Connors JM, Kuter DJ. A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies. Haematologica. 2021 04 01; 106(4):1148-1157. PMID: 32499239.
    Citations: 13     Fields:    Translation:Humans
  8. Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JCT, Fogerty AE, Waheed A, Goodarzi K, Bendapudi PK, Bornikova L, Gupta S, Leaf DE, Kuter DJ, Rosovsky RP. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020 07 23; 136(4):489-500. PMID: 32492712; PMCID: PMC7378457.
    Citations: 447     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
  9. Al-Samkari H, Goodarzi K. An Eltrombopag Red (Plasma) Alert. Acta Haematol. 2021; 144(2):227-228. PMID: 32702690.
    Citations:    Fields:    Translation:Humans
  10. Al-Samkari H, Rosovsky RP, Karp Leaf RS, Smith DB, Goodarzi K, Fogerty AE, Sykes DB, Kuter DJ. A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia. Blood Adv. 2020 01 14; 4(1):9-18. PMID: 31891657.
    Citations: 15     Fields:    Translation:Humans
  11. Al-Samkari H, Marshall AL, Goodarzi K, Kuter DJ. Romiplostim for the management of perioperative thrombocytopenia. Br J Haematol. 2018 07; 182(1):106-113. PMID: 29767837.
    Citations: 8     Fields:    Translation:Humans
  12. Al-Samkari H, Marshall AL, Goodarzi K, Kuter DJ. The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors. Haematologica. 2018 04; 103(4):e169-e172. PMID: 29242295.
    Citations: 14     Fields:    Translation:Humans
  13. Marshall AL, Goodarzi K, Kuter DJ. Romiplostim in the management of the thrombocytopenic surgical patient. Transfusion. 2015 Oct; 55(10):2505-10. PMID: 26033367.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  14. Shaz B, Goodarzi K, Malynn E, Uhl L. Improved strategy for mononuclear cell collection for donor lymphocyte infusions. Transfusion. 2006 Jun; 46(6):1044-8. PMID: 16734823.
    Citations: 1     Fields:    Translation:Humans
  15. Goodarzi K, Goodarzi M, Tager AM, Luster AD, von Andrian UH. Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat Immunol. 2003 Oct; 4(10):965-73. PMID: 12949533.
    Citations: 91     Fields:    Translation:AnimalsCells
  16. Fors BP, Goodarzi K, von Andrian UH. L-selectin shedding is independent of its subsurface structures and topographic distribution. J Immunol. 2001 Oct 01; 167(7):3642-51. PMID: 11564777.
    Citations: 7     Fields:    Translation:AnimalsCells
  17. Tager AM, Dufour JH, Goodarzi K, Bercury SD, von Andrian UH, Luster AD. BLTR mediates leukotriene B(4)-induced chemotaxis and adhesion and plays a dominant role in eosinophil accumulation in a murine model of peritonitis. J Exp Med. 2000 Aug 07; 192(3):439-46. PMID: 10934232; PMCID: PMC2193216.
    Citations: 55     Fields:    Translation:AnimalsCells
  18. McHutchison JG, Blatt LM, Ponnudurai R, Goodarzi K, Russell J, Conrad A. Ultracentrifugation and concentration of a large volume of serum for HCV RNA during treatment may predict sustained and relapse response in chronic HCV infection. J Med Virol. 1999 Apr; 57(4):351-5. PMID: 10089045.
    Citations: 4     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Goodarzi's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (117)
Co-Authors (25)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.